At Avisia Therapeutics we develop novel therapies against auto-immune diseases, such as diabetes type I, by inducing immune tolerance to the autoantigens with the use of glycans.
Company Details
- Employees
- 3
- Address
- Roetersstraat 35, Amsterdam,north Holland 1018 Wb,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Amsterdam, North Holland
Avisia Therapeutics Questions
Avisia Therapeutics's website is http://www.avisiatherapeutics.com
Avisia Therapeutics's LinkedIn profile is https://nl.linkedin.com/company/avisia-therapeutics
Avisia Therapeutics has
3 employees.
View email and phone details for 3
employees at Avisia Therapeutics.
Avisia Therapeutics's industry is
Biotechnology Research
Avisia Therapeutics's top competitors are
Lipidera Therapeutics,
Plan Therapeutics,
Audion Therapeutics,
Cristal Therapeutics,
Formula-Y,
Omnicin Therapeutics,
2-Bbb Medicines Bv,
Glycotherapeutics,
Epione Therapeutics,
Glycotreat.
Avisia Therapeutics's categories are Biotechnology Research
